Tirzepatide mitigates thoracic aortic aneurysm and dissection by alleviating the loss of the contractile phenotype in vascular smooth muscle cells and reducing vascular inflammation
Fields of Study & Subjects
Aortic Disease and Treatment Approaches
Inflammasome and immune disorders
Connective tissue disorders research
Publication details
- Journal / source
- Vascular Pharmacology
- Publisher
- Elsevier BV
- Volume
- 162
- Pages
- 107581–107581
- Publication date
- 27 January 2026
- Language
- EN